News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Permanent Headcount Down to Nil at Antisoma Inc. (ASM.L)


5/24/2011 8:38:44 AM

Troubled Antisoma says that it has no permanent members of staff and is continuing to look at options for the company.

In an interim statement, chairman Grahame Cook has been reflecting on the firm's future following the failure in Phase III of AS1413 (amonafide) in secondary acute myeloid leukaemia. Development of the drug was discontinued in February and at the time the company said it was seeking a transaction to maximise value from its remaining product assets and cash resources.

Mr Cook noted that Antisoma held cash and equivalents of £15.0 million at the end of March. It has scaled back operations to the point where "permanent headcount has now been reduced to nil and the board has been cut to five members".



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES